These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1056006)

  • 21. Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b.
    Meuth JL; Morgan EL; DiSipio RG; Hugli TE
    J Immunol; 1983 Jun; 130(6):2605-11. PubMed ID: 6602172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor.
    O'Keefe MC; Caporale LH; Vogel CW
    J Biol Chem; 1988 Sep; 263(25):12690-7. PubMed ID: 3045125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of the conglutinin binding site on the third component of human complement.
    Hirani S; Lambris JD; Müller-Eberhard HJ
    J Immunol; 1985 Feb; 134(2):1105-9. PubMed ID: 3965568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of fibronectin with complement component C3.
    Hautanen A; Keski-Oja J
    Scand J Immunol; 1983 Mar; 17(3):225-30. PubMed ID: 6402811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
    Pangburn MK; Müller-Eberhard HJ
    J Exp Med; 1980 Oct; 152(4):1102-14. PubMed ID: 6903192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of tryptic fragments of human complement factor C3.
    Eggertsen G; Hellman U; Lundwall A; Folkersen J; Sjöquist J
    Mol Immunol; 1985 Aug; 22(8):833-41. PubMed ID: 3930949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
    Spitzer RE; Stitzel AE; Pauling VL; Davis NC; West CD
    J Exp Med; 1971 Sep; 134(3 Pt 1):656-80. PubMed ID: 15776568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heat-induced thiol-disulfide interchange reaction on the third component of human complement, C3.
    Seya T; Nagasawa S
    J Biochem; 1988 May; 103(5):792-6. PubMed ID: 3182749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of complement component C3 and C3 fragments by a human platelet protein kinase. Inhibition of factor I-mediated cleavage of C3b.
    Ekdahl KN; Nilsson B
    J Immunol; 1995 Jun; 154(12):6502-10. PubMed ID: 7539023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
    Lachmann PJ; Pangburn MK; Oldroyd RG
    J Exp Med; 1982 Jul; 156(1):205-16. PubMed ID: 6177820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b).
    Gitlin JD; Rosen FS; Lachmann PJ
    J Exp Med; 1975 May; 141(5):1221-6. PubMed ID: 1168693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The separation of functionally distinct forms of the third component of human complement (C3).
    Parkes C; DiScipio RG; Kerr MA; Prohaska R
    Biochem J; 1981 Mar; 193(3):963-70. PubMed ID: 6458280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of disulphide bonds and localization of interchain linkages in the third (C3) and the fourth (C4) components of human complement.
    Janatova J
    Biochem J; 1986 Feb; 233(3):819-25. PubMed ID: 3707529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation of C3 cleavage in the alternative complement pathway.
    Fearon DT; Austen KF
    J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human membrane-bound C3 receptors. II. Physiochemical properties of the C3b and C3d receptors isolated from tonsil cells by immunoprecipitation.
    Gerdes J; Stein H
    Scand J Immunol; 1981; 13(1):77-86. PubMed ID: 7015481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The opsonic fragment of the third component of human complement (C3).
    Stossel TP; Field RJ; Gitlin JD; Alper CA; Rosen FS
    J Exp Med; 1975 Jun; 141(6):1329-47. PubMed ID: 236357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of complement fragments C3b and C3a from purified rat complement component C3 by activated cobra venom factor.
    Usami M; Ohno Y
    J Pharmacol Toxicol Methods; 2005; 52(2):260-3. PubMed ID: 16125624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.